The most common driver mutations in NSCLC involve Kirsten rat sarcoma viral oncogene homolog (KRAS), epidermal growth factor receptor (EGFR), and anaplastic lymphoma kinase[4]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.